Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines

BMC Biochemistry

Volumn 12, Issue 1, 2011, Pages

  Borgatti, Monica ^a   Mancini, Irene ^a   Bianchi, Nicoletta ^a   Guerrini, Alessandra ^a   Lampronti, Ilaria ^a   Rossi, Damiano ^a   Sacchetti, Gianni ^a   Gambari, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,7 DIMETHOXYCOUMARIN; ANTIINFLAMMATORY AGENT; BERGAMOTTIN; BERGAPTEN; CITRUS BERGAMIA EXTRACT; CYTOKINE; INTERLEUKIN 8; MESSENGER RNA; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BERGAMOT; BIOLOGICAL ACTIVITY; CELL STRAIN CUFI 1; CELL STRAIN IB3 1; CITRUS BERGAMIA; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG ACTIVITY; FRUIT; GAS CHROMATOGRAPHY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG ALVEOLUS EPITHELIUM; MASS FRAGMENTOGRAPHY; MEDICINAL PLANT; PROTEIN SECRETION; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; BRONCHUS; CELL LINE; CITRUS FRUIT; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PHYTOTHERAPY;

CITRUS AURANTIUM BERGAMIA; PSEUDOMONAS AERUGINOSA;

BRONCHI; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRUS; CYSTIC FIBROSIS; EPITHELIAL CELLS; FRUIT; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-8; MAGNETIC RESONANCE SPECTROSCOPY; PHYTOTHERAPY; PLANT EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955084668     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-12-15     Document Type: Article

References (55)

1. Cystic fibrosis. MJ Welsh LC Tsui TF Boat AL Beaudet, et al. The metabolic and molecular bases of inherited disease New York, McGraw-Hill Inc, Scriver CR, Beaudet AL, Sly WS, Valle D, 1995 3799 3876
2. Structure and function of the CFTR chloride channel. DN Sheppard MJ Welsh, Physiol Rev 1999 79 23 S45 9922375
3. Cystic fibrosis: basic science. DF McAuley JS Elborn, Paediatr Respir Rev 2000 1 93 100 10.1053/prrv.2000.0029 12531100
4. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa. AM Jones L Martin RJ Bright-Thomas ME Dodd A McDowell KL Moffitt JS Elborn AK Webb, Eur Respir J 2003 22 503 506 10.1183/09031936.03. 00004503 14516142 (Pubitemid 37098933)
5. Relation of exaggerated cytokine responses of CF airway epithelial cells to PAO1 adherence. DM Kube D Fletcher PB Davis, Respir Res 2005 6 69 10.1186/1465-9921-6-69 16008840
6. Cytokine secretion by cystic fibrosis airway epithelial cells. MN Becker MS Sauer MS Muhlebach AJ Hirsh Q Wu MW Verghese SH Randell, Am J Respir Crit Care Med 2004 169 645 653 10.1164/rccm.200207-765OC 14670800 (Pubitemid 38270902)
7. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. GE Carpagnano PJ Barnes DM Geddes ME Hodson SA Kharitonov, Am J Respir Crit Care Med 2003 167 1109 1112 10.1164/rccm.200203-179OC 12684249 (Pubitemid 36459657)
8. Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation. HR Black JR Yankaskas LG Johnson TL Noah, Am J Respir Cell Mol Biol 1998 19 210 2151 9698592
9. Mechanisms involved in cystic fibrosis airway inflammation. E Puchelle S De Bentzmann C Hubeau J Jacquot D Gaillard, Pediatr Pulmonol 2001 Suppl 23 143 145 11886121 (Pubitemid 33021831)
10. Inflammatory cytokines in cystic fibrosis lungs. TL Bonfield JR Panuska MW Konstan KA Hilliard JB Hilliard H Ghnaim M Berger, Am J Respir Crit Care Med 1995 152 6 Pt 1 2111 2118 8520783
11. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. E DiMango HJ Zar R Bryan A Prince, J Clin Invest 1995 96 5 2204 2210 10.1172/JCI118275 7593606
12. Lung inflammation as a therapeutic target in cystic fibrosis. DR Koehler GP Downey NB Sweezey AK Tanswell J Hu, Am J Respir Cell Mol Biol 2004 31 4 377 381 10.1165/rcmb.2004-0124TR 15381503 (Pubitemid 39330947)
13. Sputum biomarkers of inflammation in cystic fibrosis lung disease. SD Sagel JF Chmiel MW Konstan, Proc Am Thorac Soc 2007 4 406 417 10.1513/pats.200703-044BR 17652508 (Pubitemid 47330878)
14. Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. MS Muhlebach TL Noah, Am J Respir Crit Care Med 2002 165 911 915 11934713 (Pubitemid 34774656)
15. Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia. PO Jensen C Moser A Kharazmi T Presler C Koch N Hoiby, J Cyst Fibros 2006 5 145 151 10.1016/j.jcf.2005.12.004 16503423 (Pubitemid 44081131)
16. Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. O Tabary JM Zahm J Hinnrasky JP Couetil P Cornillet M Guenounou D Gaillard E Puchelle J Jacquot, Am J Pathol 1998 153 921 930 10.1016/S0002-9440(10)65633-7 9736040 (Pubitemid 28419044)
17. Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells. V Bezzerri M Borgatti E Nicolis I Lampronti MC Dechecchi I Mancini P Rizzotti R Gambari G Cabrini, Am J Respir Cell Mol Biol 2008 39 1 86 96 10.1165/rcmb.2007-0176OC 18258920 (Pubitemid 351883962)
18. Anti-inflammatory therapies for cystic fibrosis-related lung disease. DP Nichols MW Konstan JF Chmiel, Clin Rev Allergy Immunol 2008 35 3 135 153 10.1007/s12016-008-8081-2 18546078
19. Lung inflammation as a therapeutic target in cystic fibrosis. DR Koehler GP Downey NB Sweezey AK Tanswell J Hu, Am J Respir Cell Mol Biol 2004 31 377 381 10.1165/rcmb.2004-0124TR 15381503 (Pubitemid 39330947)
20. Herbal care for reproductive health: Ethno medicobotany from Uttara Kannada district in Karnataka, India. HV Hegde GR Hegde SD Kholkute, Complementary Therapies in Clinical Practice 2007 13 38 45 10.1016/j.ctcp.2006. 09.002 17210510
21. Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. MZ Asmawi H Kankaanranta E Moilanen H Vapaatalo, J Pharm Pharmacol 1993 45 581 584 10.1111/j.2042-7158.1993.tb05605.x 7689650 (Pubitemid 23201446)
22. Ginger - an herbal medicinal product with broad anti-inflammatory actions. R Grzanna L Lindmark CG Frondoza, J Med Food 2005 8 125 132 10.1089/jmf.2005.8.125 16117603 (Pubitemid 41008974)
23. Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities. KC Fylaktakidou DJ Hadjipavlou-Litina KE Litinas DN Nicolaides, Curr Pharm Des 2004 10 3813 3833 10.2174/1381612043382710 15579073 (Pubitemid 39409872)
24. Anti-inflammatory plant flavonoids and cellular action mechanisms. HP Kim KH Son HW Chang SS Kang, J Pharmacol Sci 2004 96 229 245 10.1254/jphs.CRJ04003X 15539763 (Pubitemid 40013328)
25. Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. JB Calixto MM Campos MF Otuki AR Santos, Planta Med 2004 70 93 103 10.1055/s-2004-815483 14994184 (Pubitemid 38299768)
26. Patented antiinflammatory plant drug development from traditional medicine. S Darshan R Doreswamy, Phytother Res 2004 18 343 357 10.1002/ptr.1475 15173991 (Pubitemid 38765121)
27. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells. MC Dechecchi E Nicolis V Bezzerri A Vella M Colombatti BM Assael Y Mettey M Borgatti I Mancini R Gambari F Becq G Cabrini, Am J Respir Cell Mol Biol 2007 36 615 624 10.1165/rcmb.2006-0200OC 17197571 (Pubitemid 46676721)
28. Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells. E Nicolis I Lampronti MC Dechecchi M Borgatti A Tamanini N Bianchi V Bezzerri I Mancini M Grazia Giri P Rizzotti R Gambari G Cabrini, Int Immunopharmacol 2008 8 12 1672 1680 10.1016/j.intimp.2008.08.001 18760383
29. Anti-inflammatory effect of miglustat in bronchial epithelial cells. MC Dechecchi E Nicolis C Norez V Bezzerri M Borgatti I Mancini P Rizzotti CM Ribeiro R Gambari F Becq G Cabrini, J Cyst Fibros 2008 7 6 555 565 10.1016/j.jcf.2008.06.002 18815075
30. Effects of rootstock on the composition of bergamot (Citrus bergamia Risso et Poiteau) essential oil. A Verzera A Trozzi F Gazea G Cicciarello A Cotroneo, J Agric Food Chem 2003 51 206 210 10.1021/jf0206872 12502409
31. Antimicrobial action of some citrus fruits oils on selected food-borne bacteria. R Dabbah VM Edwards WA Moats, Appl Microbiol 1970 19 27 31 4905947
32. Citrus - the Genus Citrus. G Dugo A Di Giacomo, Medicinal and aromatic plants Industrial profile. CRC Press, Taylor and Francis Group 2002 642
33. Coumarins in the Rutaceae. AI Gray PG Waterman, Phytochemistry 1978 17 845 864 10.1016/S0031-9422(00)88634-3
34. Citrus coumarins. WL Stanley L Jurd, J Agric Food Chem 1971 19 1106 1110 10.1021/jf60178a007
35. 7-Geranyloxycoumarin from juice oil of hassaku (Citrus hassaku) and antimicrobial effects of related coumarins. N Nakatani Y Yamada H Fuwa, Agric. Biol. Chem 1987 51 2 419 423 (Pubitemid 17056216)
36. Coumarins and anti-platelet aggregation constituents from Zanthoxylum schinifolium. IS Chen YC Lin IL Tsai CM Teng FN Ko T Ishikawa H Ishii, Phytochemistry 1995 39 1091 1097 10.1016/0031-9422(95)00054-B 7662272
37. Inhibition of mutagenesis of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) by coumarins and furanocoumarins, chromanones and furanochromanones. R Edenharder C Speth M Decker H Kolodziej O Kayser KL Platt, Mutat Res 1995 345 57 71 10.1016/0165-1218(95)90070-5 8524356 (Pubitemid 26003913)
38. Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities. KC Fylaktakidou DJ Hadjipavlou-Litina KE Litinas DN Nicolaides, Curr Pharm Des 2004 10 3813 3833 10.2174/1381612043382710 15579073 (Pubitemid 39409872)
39. Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. F Borges F Roleira N Milhazes L Santana E Uriarte, Curr Med Chem 2005 12 8 887 916 10.2174/0929867053507315 15853704 (Pubitemid 40443846)
40. Silencing of genes coding for transcription factors: biological effects of decoy oligonucleotides on cystic fibrosis bronchial epithelial cells. M Borgatti V Bezzerri I Mancini E Nicolis MC Dechecchi P Rizzotti I Lampronti R Gambari G Cabrini, Minerva Biotec 2008 20 79 83
41. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors. J Sanceau T Kaisho T Hirano J Wietzerbin, J Biol Chem 1995 270 27920 27931 10.1074/jbc.270.46.27920 7499267
42. Development of cystic fibrosis and noncystic fibrosis airway cell lines. J Zabner P Karp M Seiler SL Phillips CJ Mitchell M Saavedra M Welsh AJ Klingelhutz, Am J Phisiol Lung Cell Mol.Physiol 2003 284 844 L854
43. Tumor necrosis factor-alpha triggers mucus production in airway epithelium through an IkappaB kinase beta-dependent mechanism. JM Lora DM Zhang SM Liao T Burwell AM King PA Barker L Singh M Keaveney J Morgenstern JC Gutierrez-Ramos AJ Coyle CC Fraser, J Biol Chem 2005 280 36510 36517 10.1074/jbc.M507977200 16123045 (Pubitemid 41633925)
44. Inhibition of tumor necrosis factor-alpha-induced RANTES secretion by alkaline protease in A549 cells. TM Krunkosky K Maruo J Potempa CL Jarrett J Travis, Am J Respir Cell Mol Biol 2005 33 483 489 10.1165/rcmb.2005-0069OC 16037484 (Pubitemid 41572692)
45. Structure of the bergamottin photoprodutcs. MT Martin A Valla M Giraud JP Brouard P Morliere J Haigle R Santus, Photochem Photobiol 1993 57 222 227 10.1111/j.1751-1097.1993.tb02279.x
46. Induction of IL-6 gene expression in a CF bronchial epithelial cell line by Pseudomonas aeruginosa is dependent on transcription factors belonging to the Sp1 superfamily. M Borgatti V Bezzerri I Mancini E Nicolis MC Dechecchi I Lampronti P Rizzotti G Cabrini R Gambari, Biochem Biophys Res Commun 2007 357 977 983 10.1016/j.bbrc.2007.04.081 17466942 (Pubitemid 46693668)
47. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. W de Jager H te Velthuis BJ Prakken W Kuis GT Rijkers, Clin Diagn Lab Immunol 2003 10 133 139 12522051 (Pubitemid 36133841)
48. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. JR Kerr VS Cunniffe P Kelleher AJ Coats DL Mattey, J Med Virol 2004 74 147 155 10.1002/jmv.20158 15258981 (Pubitemid 38988872)
49. Induction by TNF- of IL-6 and IL-8 in cystic fibrosis bronchial IB3-1 epithelial cells encapsulated in alginate microbeads. M Borgatti S Mazzitelli G Breveglieri R Gambari C Nastruzzi, J Biomed Biotechnol 2010 20936184
50. Targeting transcription factor activity as a strategy to inhibit pro-inflammatory genes involved in cystic fibrosis: decoy oligonucleotides and low-molecular weight compounds. G Cabrini V Bezzerri I Mancini E Nicolis MC Dechecchi A Tamanini I Lampronti L Piccagli N Bianchi M Borgatti R Gambari, Curr Med Chem 2010 17 4392 404 10.2174/092986710793361243 20939807
51. Trimethylangelicin Reduces IL-8 Transcription and Potentiates CFTR Function. A Tamanini M Borgatti A Finotti L Piccagli V Bezzerri M Favia L Guerra I Lampronti N Bianchi F Dall'Acqua D Vedaldi A Salvador E Fabbri I Mancini E Nicolis V Casavola G Cabrini R Gambari, Am J Physiol Lung Cell Mol Physiol 2010 21148790
52. Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells. G Bergamini C Cigana C Sorio M Della Peruta A Pompella A Corti FA Huaux T Leal BM Assael P Melotti, Am J Respir Cell Mol Biol 2009 41 199 206 10.1165/rcmb.2008-0013OC 19097986
53. Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa. R Gambari M Borgatti V Bezzerri E Nicolis I Lampronti MC Dechecchi I Mancini A Tamanini G Cabrini, Biochem Pharmacol 2010 80 1887 94 10.1016/j.bcp.2010.06.047 20615393
54. Oligonucleotide decoy to NF-kappaB slowly released from PLGA microspheres reduces chronic inflammation in rat. D De Stefano G De Rosa MC Maiuri F Ungaro F Quaglia T Iuvone MP Cinelli MI La Rotonda R Carnuccio, Pharmacol Res 2009 60 33 40 10.1016/j.phrs.2009.03.012 19427583
55. Coumarinic derivatives show anti-inflammatory effects on alveolar macrophages, but their anti-elastase activity is essential to reduce lung inflammation in vivo. EY Bissonnette GM Tremblay V Turmel B Pirotte M Reboud-Ravaux, Int Immunopharmacol 2009 9 49 54 10.1016/j.intimp.2008.09.009 18840548